Medication Adherence Stressful for Psoriasis Patients

This article originally appeared here.
Share this content:
Medication Adherence Stressful for Psoriasis Patients
Medication Adherence Stressful for Psoriasis Patients

MONDAY, Oct. 3, 2016 (HealthDay News) -- Adhering to medication regimens for the treatment of psoriasis can be an additional source of considerable emotional distress for patients, according to a study published online Sept. 24 in the British Journal of Dermatology.

Rachael J. Thorneloe, Ph.D., from the University of Manchester in the United Kingdom, and colleagues interviewed 20 people with psoriasis about their perceptions of their psoriasis, medication, and adherence to medication and self-management advice.

The researchers found that adhering to recommended treatment regimens conflicted with the patients' reported management of the physical and psychological demands of living with psoriasis. For some participants, medication usage was seen as a cause of unresolved emotional distress and resulted in poor self-reported adherence, which included medication overuse, underuse, and rejection of prescribed therapies altogether. An additional source of stress was the perceived lack of engagement by clinicians regarding participants' self-management difficulties.

"We interpreted some episodes of non-adherence to psoriasis medication as rational attempts by individuals to minimize distress and to gain control over their life," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

More U.S. Teens Are Vaping, but Use of Opioids, Alcohol Falling

More U.S. Teens Are Vaping, but Use of ...

About 37 percent of 12th graders said they had vaped within the previous 12 months

Type 2 Diabetes Risk Lower in Women With Active Migraine

Type 2 Diabetes Risk Lower in Women With ...

Prevalence of active migraine decreased linearly in the 24 years prior to diabetes diagnosis

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Treatment costs less than extended-release naltrexone without negative impact on outcomes

is free, fast, and customized just for you!




Already a member?

Sign In Now »